Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.
On the afternoon of November 13, witnessed by Budi Gunadi Sadikin, Indonesia’s Minister of Health, and Luhut Binsar Pandjaitan, Indonesia’s Coordinating Minister of Maritime Affairs and Investment, Sansure Biotech signed a memorandum on localized manufacturing with its Indonesian partner UBC, introducing Sansure’s molecular diagnostic techniques to Indonesia and starting localized manufacturing. This is a milestone of Sansure’s international development and […]
Recently, under the guidance of WHO, The Robert Koch Institute (RKI), a German Reference Laboratory for Poxviruses, conducted overall evaluation on eleven PCR kits for the detection of Monkeypox Virus (MPXV) DNA, among which Sansure shows excellent performance in terms of both detection rate and specificity. Since May 2022, the rapid communication of Monkeypox around the world, especially in Europe […]
Recently, the TSure Nucleic Acid Analysis Device independently developed by Sansure obtained CE mark, which will further meet and expand the global testing market demands at all levels, and serve the construction of public health prevention and control system in every country better. Sansure’s TSure Nucleic Acid Analysis Device is a portable device that can carry LAMP thermostatic amplification reagent […]
Recently, the Human Immunodeficiency Virus Type 1 RNA Quantitative Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) independently developed by Sansure Biotech has been reviewed and approved for marketing by the National Medical Products Administration (NMPA Registration No.: 20223401175). The reagent is applicable to the quantitative detection of Human Immunodeficiency Virus Type 1 RNA in human blood samples and monitor the virological response […]
Recently, Sansure Biotech reached a strategic cooperation agreement with QuantuMDx Group Co., LTD. (hereinafter referred to as QuantuMDx) to establish cooperation relationship for global R&D and production. The two companies will further cooperate on the Q-POC™ platform, to develop multiple tests, expand the menu, and bring a series of innovative and high-performance tests. QuantuMDx is a fast-growing medical technology company […]